Ophthalmic Drug Delivery Systems Market Size (By Technology: Eye Drops, Contact Lenses, Punctal Plugs, Episcleral Implants, and Others; By Production Technology: Electrospinning, 3D Printing, Extrusion, Formulation, Micro Patterning, Compression Molding, and Others; By Delivery Route: Intraocular, Intravitreal, and Intracameral; By Material: Liposomes, Collagen, PLA-PEG, PDO/PVA, Hydrogels, TMC, and Others) – Global Industry Analysis, Market Size, Opportunities and Forecast 2022– 2030
CHAPTER 1. Industry Overview of Ophthalmic Drug Delivery Systems Market
1.1. Definition and Scope
1.1.1. Definition of Ophthalmic Drug Delivery Systems
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Ophthalmic Drug Delivery Systems Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Ophthalmic Drug Delivery Systems Market By Technology
1.2.3. Ophthalmic Drug Delivery Systems Market By Production Technology
1.2.4. Ophthalmic Drug Delivery Systems Market By Delivery Route
1.2.5. Ophthalmic Drug Delivery Systems Market By Material
1.2.6. Ophthalmic Drug Delivery Systems Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Ophthalmic Drug Delivery Systems Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Ophthalmic Drug Delivery Systems Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material Cost
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2021
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2021
4.2. R&D Status of Major Manufacturers in 2021
CHAPTER 5. Ophthalmic Drug Delivery Systems Market By Technology
5.1. Introduction
5.2. Ophthalmic Drug Delivery Systems Revenue By Technology
5.2.1. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast, By Technology, 2018-2030
5.2.2. Eye Drops
5.2.2.1. Eye Drops Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.3. Contact Lenses
5.2.3.1. Contact Lenses Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.4. Punctal Plugs
5.2.4.1. Punctal Plugs Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.5. Episceral Implants
5.2.5.1. Episceral Drops Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.6. Others
5.2.6.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
CHAPTER 6. Ophthalmic Drug Delivery Systems Market By Production Technology
6.1. Introduction
6.2. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) By Production Technology
6.2.1. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030
6.2.2. Electrospinning
6.2.2.1. Electrospinning Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
6.2.3. 3D Printing
6.2.3.1. 3D Printing Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
6.2.4. Extrusion
6.2.4.1. Extrusion Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
6.2.5. Formulation
6.2.5.1. Formulation Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
6.2.6. Micro Patterning
6.2.6.1. Micro Patterning Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
6.2.7. Compression Molding
6.2.7.1. Compression Molding Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
6.2.8. Others
6.2.8.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
CHAPTER 7. Ophthalmic Drug Delivery Systems Market By Delivery Route
7.1. Introduction
7.2. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) By Delivery Route
7.2.1. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
7.2.2. Intravitreal
7.2.2.1. Intravitreal Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
7.2.3. Intracaramel
7.2.3.1. Intraocaramel Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
7.2.4. Intraocular
7.2.4.1. Intraocular Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
CHAPTER 8. Ophthalmic Drug Delivery Systems Market By Material
8.1. Introduction
8.2. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) By Material
8.2.1. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030
8.2.2. Liposomes
8.2.2.1. Liposomes Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
8.2.3. Collagen
8.2.3.1. Collagen Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
8.2.4. PDO/PVA
8.2.4.1. PDO/PVA Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
8.2.5. Hydrogels
8.2.5.1. Liposomes Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
8.2.6. PLA-PEG
8.2.6.1. PLA-PEG Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
8.2.7. TMC
8.2.7.1. TMC Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
8.2.8. Others
8.2.8.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
CHAPTER 9. North America Ophthalmic Drug Delivery Systems Market By Country
9.1. North America Ophthalmic Drug Delivery Systems Overview
9.2. U.S.
9.2.1. U.S. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030
9.2.2. U.S. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030
9.2.3. U.S. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
9.2.4. U.S. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030
9.3. Canada
9.3.1. Canada Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030
9.3.2. Canada Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030
9.3.3. Canada Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
9.3.4. Canada Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030
9.4. North America PEST Analysis
CHAPTER 10. Europe Ophthalmic Drug Delivery Systems Market By Country
10.1. Europe Ophthalmic Drug Delivery Systems Overview
10.2. U.K.
10.2.1. U.K. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030
10.2.2. U.K. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030
10.2.3. U.K. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
10.2.4. U.K. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030
10.3. Germany
10.3.1. Germany Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030
10.3.2. Germany Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030
10.3.3. Germany Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
10.3.4. Germany Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030
10.4. France
10.4.1. France Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030
10.4.2. France Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030
10.4.3. France Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
10.4.4. France Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030
10.5. Spain
10.5.1. Spain Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030
10.5.2. Spain Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030
10.5.3. Spain Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
10.5.4. Spain Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030
10.6. Rest of Europe
10.6.1. Rest of Europe Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030
10.6.2. Rest of Europe Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030
10.6.3. Rest of Europe Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
10.6.4. Rest of Europe Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Ophthalmic Drug Delivery Systems Market By Country
11.1. Asia Pacific Ophthalmic Drug Delivery Systems Overview
11.2. China
11.2.1. China Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030
11.2.2. China Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030
11.2.3. China Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
11.2.4. China Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030
11.3. Japan
11.3.1. Japan Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030
11.3.2. Japan Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030
11.3.3. Japan Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
11.3.4. Japan Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030
11.4. India
11.4.1. India Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030
11.4.2. India Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030
11.4.3. India Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
11.4.4. India Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030
11.5. Australia
11.5.1. Australia Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030
11.5.2. Australia Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030
11.5.3. Australia Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
11.5.4. Australia Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030
11.6. South Korea
11.6.1. South Korea Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030
11.6.2. South Korea Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030
11.6.3. South Korea Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
11.6.4. South Korea Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030
11.7.2. Rest of Asia-Pacific Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030
11.7.3. Rest of Asia-Pacific Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
11.7.4. Rest of Asia-Pacific Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Ophthalmic Drug Delivery Systems Market By Country
12.1. Latin America Ophthalmic Drug Delivery Systems Overview
12.2. Brazil
12.2.1. Brazil Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030
12.2.2. Brazil Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030
12.2.3. Brazil Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
12.2.4. Brazil Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030
12.3. Mexico
12.3.1. Mexico Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030
12.3.2. Mexico Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030
12.3.3. Mexico Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
12.3.4. Mexico Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030
12.4. Rest of Latin America
12.4.1. Rest of Latin America Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030
12.4.2. Rest of Latin America Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030
12.4.3. Rest of Latin America Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
12.4.4. Rest of Latin America Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Ophthalmic Drug Delivery Systems Market By Country
13.1. Middle East & Africa Ophthalmic Drug Delivery Systems Overview
13.2. GCC
13.2.1. GCC Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030
13.2.2. GCC Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030
13.2.3. GCC Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
13.2.4. GCC Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030
13.3. South Africa
13.3.1. South Africa Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030
13.3.2. South Africa Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030
13.3.3. South Africa Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
13.3.4. South Africa Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030
13.4.2. Rest of Middle East & Africa Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030
13.4.3. Rest of Middle East & Africa Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030
13.4.4. Rest of Middle East & Africa Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Ophthalmic Drug Delivery Systems Market
14.1. Ophthalmic Drug Delivery Systems Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Technology Launches and Technology Enhancements
14.2.3. Mergers And Acquisition In Global Ophthalmic Drug Delivery Systems market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. Allergan plc
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (US$ Mn), 2021
15.1.3.2. Allergan plc2021 Ophthalmic Drug Delivery Systems Business Regional Distribution
15.1.4. Product/Service and Specification
15.1.5. Recent Developments & Business Strategy
15.1.6. Manufacturing Plant Footprint Analysis
15.2. AptarGroup, Inc.
15.3. Clearside Biomedical
15.4. Envisia Therapeutics
15.5. Ocular Therapeutix Inc.
15.6. Oculis Pharma
15.7. pSivida
15.8. Santen Pharmaceutical Co. Ltd.
15.9. Valeant Pharmaceuticals
Frequently Asked Questions
How much was the estimated value of the Global Ophthalmic Drug Delivery Systems Market in 2021 and projection by 2030?
The estimated value of Global Ophthalmic Drug Delivery Systems Market in 2021 was accounted to be US$ 12,107 Mn and market projected to reach US$ 24,556 Mn by 2030
What will be the projected CAGR for global ophthalmic drug delivery systems market during forecast period of 2022 to 2030?
The projected CAGR of ophthalmic drug delivery systems market during the analysis period of 2022 to 2030 is 8.4%.
Which are the prominent competitors operating in the market?
The prominent players of the global ophthalmic drug delivery systems market involve Allergan plc, AptarGroup, Inc., Clearside Biomedical, Envisia Therapeutics, Ocular Therapeutix Inc., Oculis Pharma, pSivida, Santen Pharmaceutical Co. Ltd., and Valeant Pharmaceuticals.
Which region held the dominating position in the global ophthalmic drug delivery systems market?
North America held the dominating share for ophthalmic drug delivery systems during the analysis period of 2022 to 2030.
Which region exhibited the fastest growing CAGR for the forecast period of 2022 to 2030?
Asia-Pacific region exhibited fastest growing CAGR for ophthalmic drug delivery systems during the analysis period of 2022 to 2030.
What are the current trends and dynamics in the global ophthalmic drug delivery systems market?
Rising burden of eye disorders worldwide, rising technological advancements in ophthalmic drug delivery, and growing demand from nanotechnology to get improved results drives the growth of global ophthalmic drug delivery systems market.
By segment technology, which sub-segment held the maximum share?
Based on technology, eye drops segment held the maximum share for ophthalmic drug delivery systems market in 2021.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
